Norges Bank
SRNE

Norges Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Norges Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,125,259
Closed -$2.77M – 2196
2022
Q4 		$2.77M Buy
3,125,259
+223,776
+8% +$297K ﹤0.01% 1924
2022
Q3 		$4.56M Hold
2,901,483
– – ﹤0.01% 1785
2022
Q2 		$5.83M Buy
2,901,483
+717,900
+33% +$1.24M ﹤0.01% 1732
2022
Q1 		$5.09M Buy
2,183,583
+1,255,291
+135% +$3.92M ﹤0.01% 1867
2021
Q4 		$4.32M Buy
928,292
+215,757
+30% +$1.34M ﹤0.01% 1929
2021
Q3 		$5.44M Buy
+712,535
New +$6.04M ﹤0.01% 1913

Other funds holding SRNE

PP
Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
OFA
Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return
CGA
Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
GBWM
Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return